vs
NORTHRIM BANCORP INC（NRIM）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是NORTHRIM BANCORP INC的1.2倍（$75.5M vs $61.2M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 11.6%），NORTHRIM BANCORP INC自由现金流更多（$133.9M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 18.4%）
Northrim Bancorp Inc是总部位于美国阿拉斯加州的区域银行控股企业，提供商业及个人存贷款、按揭产品、财富管理等多元化金融服务，服务覆盖本地小微企业、个人消费者及企业客户群体。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NRIM vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$61.2M
营收增速更快
PBYI
高出16.1%
11.6%
自由现金流更多
NRIM
多$119.5M
$14.4M
两年增速更快
PBYI
近两年复合增速
18.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.2M | $75.5M |
| 净利润 | — | — |
| 毛利率 | 79.9% | 69.3% |
| 营业利润率 | 27.2% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 11.6% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-2.80 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NRIMPBYI
| Q4 25 | $61.2M | $75.5M | ||
| Q3 25 | $77.2M | $54.5M | ||
| Q2 25 | $61.4M | $52.4M | ||
| Q1 25 | $55.8M | $46.0M | ||
| Q4 24 | $54.8M | $59.1M | ||
| Q3 24 | $51.0M | $80.5M | ||
| Q2 24 | $46.5M | $47.1M | ||
| Q1 24 | $43.7M | $43.8M |
净利润NRIMPBYI
| Q4 25 | — | — | ||
| Q3 25 | $27.1M | $8.8M | ||
| Q2 25 | $11.8M | $5.9M | ||
| Q1 25 | $13.3M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.8M | $20.3M | ||
| Q2 24 | $9.0M | $-4.5M | ||
| Q1 24 | $8.2M | $-4.8M |
毛利率NRIMPBYI
| Q4 25 | 79.9% | 69.3% | ||
| Q3 25 | 84.0% | 77.7% | ||
| Q2 25 | 78.5% | 76.5% | ||
| Q1 25 | 84.1% | 77.1% | ||
| Q4 24 | 77.8% | 76.4% | ||
| Q3 24 | 75.2% | 63.9% | ||
| Q2 24 | 79.1% | 77.4% | ||
| Q1 24 | 78.2% | 75.5% |
营业利润率NRIMPBYI
| Q4 25 | 27.2% | 22.7% | ||
| Q3 25 | 44.8% | 17.6% | ||
| Q2 25 | 25.7% | 12.7% | ||
| Q1 25 | 31.5% | 8.7% | ||
| Q4 24 | 24.3% | 22.6% | ||
| Q3 24 | 22.8% | 27.4% | ||
| Q2 24 | 24.9% | -4.6% | ||
| Q1 24 | 24.1% | -5.3% |
净利率NRIMPBYI
| Q4 25 | — | — | ||
| Q3 25 | 35.1% | 16.2% | ||
| Q2 25 | 19.2% | 11.2% | ||
| Q1 25 | 23.9% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 17.3% | 25.2% | ||
| Q2 24 | 19.4% | -9.6% | ||
| Q1 24 | 18.8% | -11.0% |
每股收益（稀释后）NRIMPBYI
| Q4 25 | $-2.80 | $0.26 | ||
| Q3 25 | $1.20 | $0.17 | ||
| Q2 25 | $2.09 | $0.12 | ||
| Q1 25 | $2.38 | $0.06 | ||
| Q4 24 | $-1.83 | $0.40 | ||
| Q3 24 | $0.39 | $0.41 | ||
| Q2 24 | $1.62 | $-0.09 | ||
| Q1 24 | $1.48 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $12.8M | $22.7M |
| 股东权益账面价值 | $326.5M | $130.3M |
| 总资产 | $3.3B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.04× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NRIMPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务NRIMPBYI
| Q4 25 | $12.8M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $23.0M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益NRIMPBYI
| Q4 25 | $326.5M | $130.3M | ||
| Q3 25 | $315.7M | $115.3M | ||
| Q2 25 | $290.2M | $104.7M | ||
| Q1 25 | $279.8M | $97.1M | ||
| Q4 24 | $267.1M | $92.1M | ||
| Q3 24 | $260.1M | $71.1M | ||
| Q2 24 | $247.2M | $48.5M | ||
| Q1 24 | $239.3M | $51.0M |
总资产NRIMPBYI
| Q4 25 | $3.3B | $216.3M | ||
| Q3 25 | $3.3B | $202.9M | ||
| Q2 25 | $3.2B | $194.9M | ||
| Q1 25 | $3.1B | $196.2M | ||
| Q4 24 | $3.0B | $213.3M | ||
| Q3 24 | $3.0B | $220.7M | ||
| Q2 24 | $2.8B | $205.0M | ||
| Q1 24 | $2.8B | $214.1M |
负债/权益比NRIMPBYI
| Q4 25 | 0.04× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.09× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $139.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $133.9M | $14.4M |
| 自由现金流率自由现金流/营收 | 218.9% | 19.1% |
| 资本支出强度资本支出/营收 | 8.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $235.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流NRIMPBYI
| Q4 25 | $139.3M | $14.4M | ||
| Q3 25 | $92.7M | $9.7M | ||
| Q2 25 | $-4.4M | $14.1M | ||
| Q1 25 | $16.5M | $3.6M | ||
| Q4 24 | $-8.7M | $15.6M | ||
| Q3 24 | $-201.0K | $11.0M | ||
| Q2 24 | $-38.5M | $1.0M | ||
| Q1 24 | $-5.5M | $11.2M |
自由现金流NRIMPBYI
| Q4 25 | $133.9M | $14.4M | ||
| Q3 25 | $89.9M | $9.7M | ||
| Q2 25 | $-4.7M | $14.1M | ||
| Q1 25 | $16.3M | $3.6M | ||
| Q4 24 | $-9.3M | $15.6M | ||
| Q3 24 | $-330.0K | $11.0M | ||
| Q2 24 | $-39.4M | $1.0M | ||
| Q1 24 | $-6.6M | — |
自由现金流率NRIMPBYI
| Q4 25 | 218.9% | 19.1% | ||
| Q3 25 | 116.5% | 17.7% | ||
| Q2 25 | -7.7% | 26.8% | ||
| Q1 25 | 29.3% | 7.7% | ||
| Q4 24 | -17.1% | 26.4% | ||
| Q3 24 | -0.6% | 13.7% | ||
| Q2 24 | -84.7% | 2.1% | ||
| Q1 24 | -15.1% | — |
资本支出强度NRIMPBYI
| Q4 25 | 8.9% | 0.0% | ||
| Q3 25 | 3.5% | 0.0% | ||
| Q2 25 | 0.5% | 0.0% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 1.1% | 0.0% | ||
| Q3 24 | 0.3% | 0.0% | ||
| Q2 24 | 1.9% | 0.0% | ||
| Q1 24 | 2.4% | 0.0% |
现金转化率NRIMPBYI
| Q4 25 | — | — | ||
| Q3 25 | 3.42× | 1.10× | ||
| Q2 25 | -0.37× | 2.41× | ||
| Q1 25 | 1.24× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.02× | 0.54× | ||
| Q2 24 | -4.27× | — | ||
| Q1 24 | -0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NRIM
| Community Banking Segment | $44.3M | 72% |
| Specialty Finance Segment | $7.4M | 12% |
| Other | $4.7M | 8% |
| Home Mortgage Lending Segment | $3.6M | 6% |
| Credit And Debit Card | $1.2M | 2% |
PBYI
暂无分部数据
